Fig. 7From: Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancerPredicted tumor-infiltrating lymphocyte (TIL) values for I-SPY patients based on the proposed composite model, stratified by recurrence status in box plots for (a) hormone receptor-negative (HR−)/human epidermal growth factor receptor 2-negative (HER2−), (b) HR+/HER2−, and (c) HER2+ patientsBack to article page